Therapeutic Asset Ratings
6,308 results matching 1 filter
91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Dostarlimab
Female Reproductive System Neoplasm
GlaxoSmithKline
P1/2
CCC
(48)
DOXORUBICIN
EZB-MYC+ Diffuse Large B-Cell Lymphoma
The First Affiliated Hospital with Nanjing Medical University
P1/2
CCC
(48)
DPC-A69448
Hemophilia
Hangzhou Gensciences Biopharmaceutical Co., Ltd.
P1/2
CCC
(48)
DS3790a
Hematopoietic And Lymphoid System Neoplasm
Daiichi Sankyo
P1/2
CCC
(48)
dt2216
Fibrolamellar Hepatocellular Carcinoma
Children's Oncology Group
P1/2
CCC
(48)
Dualcar-Nk19/70 Cell
B-Cell Non-Hodgkin Lymphoma
Aibin Liang,MD,Ph.D.
P1/2
CCC
(48)
Dual-Target Antigen-Selected Car-Nk
Prostate Cancer
Essen Biotech
P1/2
CCC
(48)
Dual-Target Car-Nk Cells
Cancer
Beijing Biotech
P1/2
CCC
(48)
Dual-Target Car-Nk Cells
Breast Cancer
Beijing Biotech
P1/2
CCC
(48)
Durvalumab
Breast Disorder
AstraZeneca
P1/2
CCC
(48)
Durvalumab
Fibrolamellar Hepatocellular Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P1/2
CCC
(48)
Durvalumab
Folliculotropic Mycosis Fungoides
City of Hope Medical Center
P1/2
CCC
(48)
Durvalumab
Neuroendocrine Carcinoma
IDEAYA Biosciences
P1/2
CCC
(48)
Durvalumab
Ovarian Disorder
AstraZeneca
P1/2
CCC
(48)
Durvalumab
Mature T-Cell And NK-Cell Non-Hodgkin Lymphoma
City of Hope Medical Center
P1/2
CCC
(48)
Durvalumab
Mycosis Fungoides
City of Hope Medical Center
P1/2
CCC
(48)
Durvalumab
Peripheral T-Cell Lymphoma, Not Otherwise Specified
City of Hope Medical Center
P1/2
CCC
(48)
e-602
Urothelial Carcinoma
Palleon Pharmaceuticals, Inc.
P1/2
CCC
(48)
e7386
Hepatocellular Carcinoma
Eisai Inc.
P1/2
CCC
(48)
eb103
B-Cell Non-Hodgkin Lymphoma
Estrella Biopharma, Inc.
P1/2
CCC
(48)
eb103
HIV-Associated Cancer
Estrella Biopharma, Inc.
P1/2
CCC
(48)
eb103
Non-Hodgkin Lymphoma
Estrella Biopharma, Inc.
P1/2
CCC
(48)
EB-701
Nonpapillary Renal Cell Carcinoma
Beijing Biotech
P1/2
CCC
(48)
eb-701/ca9-nk
Nonpapillary Renal Cell Carcinoma
Beijing Biotech
P1/2
CCC
(48)
Eb-Dnk101 Dual-Targeting Car-Nk Cells
Metastatic Neoplasm
Beijing Biotech
P1/2
CCC
(48)
Showing 1101 to 1125 of 6,308 assets
Previous
Page 45 of 253
Next